Oneness Biotech Co., Ltd. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was TWD 12.729 million compared to TWD 31.665 million a year ago. Operating loss was TWD 170.592 million compared to TWD 195.597 million a year ago. Net loss was TWD 472.726 million compared to net income of TWD 492.374 million a year ago. Basic loss per share from continuing operations was TWD 1.24 compared to basic earnings per share from continuing operations of TWD 1.39 a year ago. Diluted loss per share from continuing operations was TWD 1.24 compared to diluted earnings per share from continuing operations of TWD 1.3 a year ago. For the half year, sales was TWD 23.710 million compared to TWD 34.910 million a year ago. Operating loss was TWD 446.154 million compared to TWD 340.618 million a year ago. Net loss was TWD 355.540 million compared to net income of TWD 303.176 million a year ago. Basic loss per share from continuing operations was TWD 0.94 compared to basic earnings per share from continuing operations of TWD 0.86 a year ago. Diluted loss per share from continuing operations was TWD 0.94 compared to diluted earnings per share from continuing operations of TWD 0.81 a year ago.